Advances in Ewing's sarcoma research: where are we now and what lies ahead?

JL Ordóñez, D Osuna, D Herrero, E de Alava… - Cancer research, 2009 - AACR
Ewing's sarcoma family tumors (EFT) are characterized by specific chromosomal
translocations, which lead to EWS/ETS transcription factors. Elucidation of EWS/ETS target …

EWS/FLI1 target genes and therapeutic opportunities in Ewing sarcoma

F Cidre-Aranaz, J Alonso - Frontiers in oncology, 2015 - frontiersin.org
Ewing sarcoma is an aggressive bone malignancy that affect children and young adults.
Ewing sarcoma is the second most common primary bone malignancy in pediatric patients …

Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma

HF Zhang, CS Hughes, W Li, JZ He, D Surdez… - Cancer discovery, 2021 - AACR
Cancer cells must overcome anoikis (detachment-induced death) to successfully
metastasize. Using proteomic screens, we found that distinct oncoproteins upregulate IL1 …

Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1

EM Tomazou, NC Sheffield, C Schmidl, M Schuster… - Cell reports, 2015 - cell.com
Transcription factor fusion proteins can transform cells by inducing global changes of the
transcriptome, often creating a state of oncogene addiction. Here, we investigate the role of …

Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite

TGP Grünewald, V Bernard, P Gilardi-Hebenstreit… - Nature …, 2015 - nature.com
Deciphering the ways in which somatic mutations and germline susceptibility variants
cooperate to promote cancer is challenging. Ewing sarcoma is characterized by fusions …

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells

N Riggi, ML Suvà, C De Vito, P Provero… - Genes & …, 2010 - genesdev.cshlp.org
Cancer stem cells (CSCs) display plasticity and self-renewal properties reminiscent of
normal tissue stem cells, but the events responsible for their emergence remain obscure. We …

Transcriptional programs define intratumoral heterogeneity of Ewing sarcoma at single-cell resolution

MM Aynaud, O Mirabeau, N Gruel, S Grossetête… - Cell reports, 2020 - cell.com
Summary EWSR1-FLI1, the chimeric oncogene specific for Ewing sarcoma (EwS), induces a
cascade of signaling events leading to cell transformation. However, it remains elusive how …

[HTML][HTML] Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions

J Vibert, O Saulnier, C Collin, F Petit, KJE Borgman… - Molecular Cell, 2022 - cell.com
Many cancers are characterized by gene fusions encoding oncogenic chimeric transcription
factors (TFs) such as EWS:: FLI1 in Ewing sarcoma (EwS). Here, we find that EWS:: FLI1 …

[HTML][HTML] Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets

MC Baldauf, MF Orth, M Dallmayer, A Marchetto… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Ewing sarcoma is an undifferentiated small-round-cell sarcoma. Although molecular
detection of pathognomonic EWSR1-ETS fusions such as EWSR1-FLI1 enables definitive …

YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells

L Bierbaumer, AM Katschnig, B Radic-Sarikas… - Oncogenesis, 2021 - nature.com
Ewing sarcoma (EwS) is a highly metastatic bone cancer characterized by the ETS fusion
oncoprotein EWS-FLI1. EwS cells are phenotypically highly plastic and switch between …